The Bladder Instillation Comparison Study

• Status: Unknown status
• Trial end date: 2019-04-01
• Target enrollment: 0
• Participant gender: All

Summary

To compare the efficacy of Mitomycin C vs. Gemcitabine vs. no adjuvant treatment as a single intraoperative instillation in preventing recurrence of bladder cancer.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Spectrum Health Hospitals
• Treatments: Gemcitabine; Mitomycin; Mitomycins

Criteria

Inclusion Criteria:

1. sign an informed consent for the study

2. be scheduled for a TURBT for suspected non-muscle invasive bladder tumor.

Exclusion Criteria:

1. patients unable to consent for themselves

2. individuals under 18 years old

3. pregnant women

4. prisoners

5. patients with known allergy or intolerance to the mitomycin C or Gemcitabine

6. any other sound medical, psychiatric and/or social reason as determined by the investigator.